Teladoc Health, Inc. (TDOC) financial statements and ratios from SEC XBRL: revenue $2.53B (TTM), net margin -7.9%, revenue growth -4.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.53B |
| Net Margin | -7.9% |
| Revenue Growth (YoY) | -4.0% |
| EPS Growth (YoY) | 10.5% |
| FCF Growth (YoY) | -29.3% |
| Price / Book | 0.89 |
| Price / Sales | 0.47 |
| FCF Yield | 21.7% |
| DCF Value (model) | $28.12 |
| DCF Upside vs Price | 334.0% |
| Altman Z-Score | -6.70 (distress) |
| Sector P/E (Healthcare) | 21.6 |
TDOC overview · TDOC earnings · TDOC KPIs · TDOC investor relations · TDOC ownership · TDOC peers · TDOC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.